Evaluation of ROS1 Expression in a Large Cohort of Early Stage Lung Cancer

被引：0
|
作者：
Dyrbekk, A. P. [1 ]
Warsame, A. [2 ]
Lund-Iversen, M. [2 ]
Suhrke, P. [1 ]
Helland, A. [3 ,4 ]
Brustugun, O. T. [5 ]
机构：
[1] Vestfold Hosp Trust, Pathol Dept, Tonsberg, Norway
[2] Oslo Univ Hosp, Dept Pathol, Oslo, Norway
[3] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[4] Oslo Univ Hosp, Inst Canc Res, Oslo, Norway
[5] Vestre Viken Hosp Trust, Drammen Hosp, Sect Oncol, Drammen, Norway
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
molecular pathology; ROS-1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P59.18
引用
收藏
页码：S1155 / S1156
页数：2
相关论文
共 50 条
  • [41] Comprehensive evaluation of the test for 5′-/3′-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer
    Mitiushkina, Natalia, V
    Romanko, Alexandr A.
    Preobrazhenskaya, Elena, V
    Tiurin, Vladislav, I
    Ermachenkova, Tatiana, I
    Martianov, Alexandr S.
    Mulkidjan, Rimma S.
    Sokolova, Tatiana N.
    Kholmatov, Maksim M.
    Bizin, Ilya, V
    Ivantsov, Alexandr O.
    Yatsuk, Olga S.
    Zaitseva, Olga A.
    Iyevleva, Aglaya G.
    Kuligina, Ekatherina Sh
    Imyanitov, Evgeny N.
    CANCER MEDICINE, 2022, 11 (17): : 3226 - 3237
  • [42] Advances and future directions in ROS1 fusion-positive lung cancer
    Boulanger, Mary C.
    Schneider, Jaime L.
    Lin, Jessica J.
    ONCOLOGIST, 2024, 29 (11): : 943 - 956
  • [43] ROS1 RNA In Situ Hybridization (RNA-ISH) for Detecting ROS1 Rearrangements in Lung Adenocarcinoma
    Helland, Timothy
    Neyaz, Azfar
    Deshpande, Vikram
    Hung, Yin
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1781 - 1781
  • [44] ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas
    Sholl, Lynette M.
    Sun, Heather
    Butaney, Mohit
    Zhang, Chengsheng
    Lee, Charles
    Jaenne, Pasi A.
    Rodig, Scott J.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (09) : 1441 - 1449
  • [45] Lung Cancer with Concurrent EGFR Mutation and ROS1 Rearrangement: A Case Report
    Zhu, Y.
    Xu, C.
    Wang, W.
    Liao, X.
    Du, K.
    Zhuang, W.
    Fang, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2261 - S2262
  • [46] Activation of YAP1 confers ROS1 inhibitor resistance in ROS1-rearranged lung cancer
    Yamazoe, Masatoshi
    Ozasa, Hiroaki
    Ogimoto, Tatsuya
    Hosoya, Kazutaka
    Ajimizu, Hitomi
    Yasuda, Yuto
    Funazo, Tomoko
    Tsuji, Takahiro
    Yoshida, Hironori
    Sakamori, Yuichi
    Kim, Young Hak
    Hirai, Toyohiro
    CANCER SCIENCE, 2021, 112 : 890 - 890
  • [47] Introduction of an EQA scheme for ROS1, RET and MET testing in lung cancer
    Fairley, J.
    Deans, Z. C.
    VIRCHOWS ARCHIV, 2017, 471 : S165 - S165
  • [48] Zeroing in on ROS1 Rearrangements in Non-Small Cell Lung Cancer
    Stumpfova, Magda
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4222 - 4224
  • [49] ROS1 rearranged nonsmall cell lung cancer and crizotinib: An Indian experience
    Noronha, V
    Chandrakanth, M., V
    Joshi, A. P.
    Patil, V
    Chougule, A.
    Mahajan, A.
    Janu, A. K.
    Chanana, R.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2017, 54 (02) : 436 - 438
  • [50] Activation of YAP1 confers ROS1 inhibitor resistance in ROS1-rearranged lung cancer
    Yamazoe, Masatoshi
    Ozasa, Hiroaki
    Ohgimoto, Tetsuya
    Hosoya, Kazutaka
    Ajimizu, Hitomi
    Funazo, Tomoko
    Yasuda, Yuto
    Tsuji, Takahiro
    Yoshida, Hironori
    Itotani, Ryo
    Sakamori, Yuichi
    Kim, Young Hak
    Toyohiro, Hirai
    CANCER RESEARCH, 2021, 81 (13)
12345